Hoven-Gondrie Miriam L, Thijssens Katja M J, Geertzen Jan H B, Pras Elisabeth, van Ginkel Robert J, Hoekstra Harald J
Department of Surgical Oncology, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, Groningen, 9700 RB, The Netherlands.
Ann Surg Oncol. 2008 May;15(5):1502-10. doi: 10.1245/s10434-008-9850-0. Epub 2008 Mar 11.
With the combined treatment procedure of isolated limb perfusion (ILP), delayed surgical resection and external beam radiotherapy (EBRT) for locally advanced soft tissue sarcomas (STS) of the extremities, limb salvage rates of more than 80% can be achieved. However, long-term damage to the healthy surrounding tissue cannot be prevented. We studied the late effects on the normal tissue using the LENT-SOMA scoring system.
A total of 32 patients-median age 47 (range 14-71) years-were treated for a locally advanced STS with ILP, surgical resection and often adjuvant 60-70 Gy EBRT. After a median follow-up of 88 (range 17-159) months, the patients were scored, using the LENT-SOMA scales, for the following late tissue damage: muscle/soft tissue, peripheral nerves, skin/subcutaneous tissue and vessels.
According to the individual SOM parameters of the LENT-SOMA scales, 20 patients (63%) scored grade-3 toxicity on one or more separate items, reflecting severe symptoms with a negative impact on daily activities. Of these patients, 3 (9%) even scored grade-4 toxicity on some of the parameters, denoting irreversible functional damage necessitating major therapeutic intervention.
In evaluating long-term morbidity after a combined treatment procedure for STS of the extremity, using modified LENT-SOMA scores, two-thirds of patients were found to have experienced serious late toxic effects.
采用孤立肢体灌注(ILP)、延迟手术切除和外照射放疗(EBRT)联合治疗方案治疗四肢局部晚期软组织肉瘤(STS),肢体挽救率可达80%以上。然而,无法预防对周围健康组织的长期损害。我们使用LENT-SOMA评分系统研究了对正常组织的晚期影响。
共有32例患者——中位年龄47岁(范围14 - 71岁)——接受了ILP、手术切除及通常为60 - 70 Gy的辅助EBRT治疗局部晚期STS。中位随访88个月(范围17 - 159个月)后,使用LENT-SOMA量表对患者以下晚期组织损伤进行评分:肌肉/软组织、周围神经、皮肤/皮下组织和血管。
根据LENT-SOMA量表的个体SOM参数,20例患者(63%)在一个或多个单独项目上评分为3级毒性,反映出严重症状,对日常活动有负面影响。其中3例患者(9%)在某些参数上甚至评分为4级毒性,表明存在不可逆的功能损害,需要进行重大治疗干预。
在使用改良的LENT-SOMA评分评估肢体STS联合治疗后的长期发病率时,发现三分之二的患者经历了严重的晚期毒性反应。